Published • loading... • Updated
Céline Dion Making a Comeback After Years Away From the Stage over Health
The 16-show run follows years of treatment and rehabilitation after a rare neurological disorder sidelined the singer.
- Dion will open a residency at the Plenitude Arena in Paris beginning Sept. 12, marking her return to the stage following recovery from stiff person syndrome, a rare autoimmune disorder.
- Four years after sharing her SPS diagnosis, the singer is reemerging into public life; the 2024 documentary revealed the debilitating pain and muscle paralysis that previously forced her to cancel performances.
- Preparing for these French shows, Dion completes 90-minute Pilates sessions three times a week and takes ballet classes with a local company to rebuild her strength.
- Tickets sold so quickly that she has already started selling dates for a three-week residency in May 2027, signaling demand for her return to performing.
- Because there are no FDA-approved treatments for the condition, Dion's foundation donated $2 million in 2024 for research into autoimmune neurological disorders, extending her advocacy beyond performance.
Insights by Ground AI
30 Articles
30 Articles
The diva had been away from the public for more than six years, since it had to interrupt its last tour, started in 2019, first because of the pandemic and then because of health problems.
·Warsaw, Poland
Read Full Article
In a few days, Céline Dion will be back on stage in Paris, embodying the Diva type like a few others: great voice, extravagant outfits, personality cult. But what does it mean to perform in a divinity?
·Vienna, Austria
Read Full Article
This weekend, the Canadian singer will return to the stage after five years away from the big shows for her fight against rigid person syndrome. The artist plans to offer 16 shows at the Plenitude Arena in Paris.
Coverage Details
Total News Sources30
Leaning Left0Leaning Right2Center27Last UpdatedBias Distribution93% Center
Bias Distribution
- 93% of the sources are Center
93% Center
C 93%
Factuality
To view factuality data please Upgrade to Premium
